5jxe
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Human PD-1 ectodomain complexed with Pembrolizumab Fab== | |
- | + | <StructureSection load='5jxe' size='340' side='right' caption='[[5jxe]], [[Resolution|resolution]] 2.90Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[5jxe]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5JXE OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5JXE FirstGlance]. <br> | |
- | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5jxe FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5jxe OCA], [http://pdbe.org/5jxe PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5jxe RCSB], [http://www.ebi.ac.uk/pdbsum/5jxe PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5jxe ProSAT]</span></td></tr> | |
- | [[ | + | </table> |
- | [[Category: Bharath, S | + | == Disease == |
+ | [[http://www.uniprot.org/uniprot/PDCD1_HUMAN PDCD1_HUMAN]] Systemic lupus erythematosus;Multiple sclerosis. Systemic lupus erythematosus 2 (SLEB2) [MIM:[http://omim.org/entry/605218 605218]]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.<ref>PMID:12402038</ref> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/PDCD1_HUMAN PDCD1_HUMAN]] Inhibitory cell surface receptor involved in the regulation of T-cell function during immunity and tolerance. Upon ligand binding, inhibits T-cell effector functions in an antigen-specific manner. Possible cell death inducer, in association with other factors.<ref>PMID:21276005</ref> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Bharath, S R]] | ||
+ | [[Category: Na, Z]] | ||
[[Category: Song, H]] | [[Category: Song, H]] | ||
- | [[Category: | + | [[Category: Human pd-1 pembrolizumab fab]] |
+ | [[Category: Immune system]] |
Revision as of 15:57, 10 August 2016
Human PD-1 ectodomain complexed with Pembrolizumab Fab
|